This article is available online at http://www.jlr.org cells ( 2-5 ), a hallmark of atherosclerosis, it is important to clarify the mechanisms that mediate the hydrolysis of CE in foam cells (2) (3) (4) (5) .
Mice
C57BL/6 was purchased from Clea (Tokyo, Japan). Mice were maintained and cared for according to the regulations of the Animal Care Committee of the University of Tokyo.
Vector and transfection
Mouse wild-type or mutant NCEH cDNA was subcloned into pcDNA3.1, pcDNA.3.1/myc-His (Invitrogen, Carlsbad, CA), or pCMV-Tag4 (Stratagene, La Jolla, CA) and used as NCEH or fl ag-tagged NCEH. Furthermore, NCEH cDNA or mutant NCEH cDNA was subcloned into pEGFP-N3 (Clontech, Palo Alto, CA) and used as NCEH-green fl uorescent protein (GFP) fusion expression vector. Transfection was performed using Lipofectamin2000 (Invitrogen), Superfect (Qiagen, Hilden, Germany), or Fugene HD (Roche) as transfection reagents. and Ser 191 were replaced by alanine. Site-directed mutagenesis was performed using the megaprimer method ( 23 ) . The oligonucleotides used to generate the mega primers are as follows: N270Q, 5 ′ -gattgtgaacCAGcacacttcac-3 ′ ; N367Q, 5 ′ -agt gcgggt gtgCAGgtgaccttgga-3 ′ ; N389Q, 5 ′ -ctggccgaccCAGttctccgt-3 ′ ; G114A, 3 ′ -cccagcctccGGCgtggatata-5 ′ ; and S191A, 3 ′ -tcc caccagc GGCgtctc cagaaat-5 ′ .
Site-directed mutagenesis and mutagenic oligonucleotides

Production of ΔN-NCEH, ΔN-NCEH-GFP, NCEH 1-33 -GFP, and NCEH 1-89 -GFP
A mutant NCEH that lacks the coding region for the N-terminal region of NCEH (1-33 amino acids) was generated by PCR using as a forward primer, 5 ′ -cctggggacaatgctgctggacgccac-3 ′ .
The full-length NCEH cDNA was used as a template. The PCR product was subcloned into the pcDNA3.1 or pEGFP-N3 vector, yielding ⌬ N-NCEH and ⌬ N-NCEH-GFP, respectively. In addition, the coding region for the N-terminal 1-33 and 1-89 amino acids of NCEH was generated by PCR and subcloned into the pEG-FP-N3 vector, yielding NCEH 1-33 -GFP and NCEH 1-89 -GFP, respectively. The primers used were as follows: NCEH 1-33 -GFP, forward primer, 5 ′ -ctggggacaatgaggtcgt-3 ′ and reverse primer, 5 ′ -cagtttccaggggtcggac-3 ′ ; NCEH 1-89 -GFP, forward primer, 5 ′ -ctggg ga caatgaggtcgt-3 ′ and reverse primer,5 ′ -cccatcgaagtcggtgtct-3 ′ .
Adenovirus
We used the adenovirus overexpressing LacZ, NCEH, or HSL that had been used in the previous report ( 18 ) .
Antibodies
Amino acid residues of human NCEH (amino acids 83-164) was expressed in bacteria as a glutathione S -transferase fusion protein, which was purifi ed by glutathione affi nity chromatography and used for immunization of rabbits according to the standard protocols as described previously ( 24 ) . From serum samples with high antibody titers, IgG fractions were isolated using a protein G column (GE Healthcare). Serum of nonimmunized rabbits was used as a control. This rabbit polyclonal antibody of human NCEH recognized both human and mouse NCEH. Furthermore, we used rabbit polyclonal antibody of mouse NCEH, which recognizes amino acid residues containing catalytic core domain of mouse NCEH (amino acids 99-250). This antibody was already used in our previous report ( 18 ) .
We used rabbit anti-HSL polyclonal antibody, which was used in the previous report ( 16 ) . Mouse anti-ACAT1 monoclonal antibody was also used in the previous report ( 25 ) . Mouse anti-protein disulfi de isomerase (PDI) monoclonal antibody was from Stressgen, Assay Designs (Ann Arbor, MI). Mouse anti-FLAG monoclonal protected against diet-induced atherosclerosis in LDL receptor knockout mice ( 17 ) . However, the effects of loss of function of CEH on nCEH activity in macrophages have not been reported. Furthermore, a mouse ortholog of CEH, TGH, was expressed at a low level in MPMs ( 13 ) and possessed a negligible nCEH activity compared with its hydrolase activity toward p -nitrophenyl butyrate (PNPB), triolein, and monoolein ( 18 ) . In contrast, NCEH is robustly expressed in MPMs as well as in macrophage foam cells in atherosclerotic lesions, and the knockdown of NCEH by short interference RNA signifi cantly reduced nCEH activity in MPMs ( 18 ) . Therefore, NCEH is more likely to be involved in the hydrolysis of CE in MPMs.
Recently, it has become clear that NCEH is a mouse ortholog of KIAA1363. KIAA1363 was initially identifi ed as a membrane-bound serine hydrolase whose expression is upregulated in invasive cancer cells ( 19 ) . Subsequent studies in the labs of Cravatt and Casida have shown that KIAA1363 is chlorpyrifos oxon-binding protein ( 14 ) , which has 2-acetyl monoalkylglycerol hydrolase activity and serves as a central node in an ether lipid signaling network that bridges platelet-activating factor and lysophosphatidic acid ( 20 ) . These fi ndings regarding the novel function of KIAA1363 do not negate the possibility that KIAA1363 also serves as NCEH because many lipid-metabolizing enzymes act on multiple substrates, thus being multifunctional.
Despite these intriguing functions of NCEH/KIAA1363, it is poorly understood where and how NCEH is associated with membranes and how posttranslational modifi cations infl uence its function. In this study, we show that NCEH is a single-membrane-spanning endoplasmic reticulum (ER) protein that anchors to the ER membrane via an N-terminal hydrophobic segment. Its catalytic and lipidbinding domains are located in the ER lumen. N-linked glycation at Asn 270 is crucial for its enzymatic activity.
MATERIALS AND METHODS
Materials
Lecithin, BSA fraction V (BSA), adenosine 3 ′ ,5 ′ -cyclic monophosphate sodium salt monohydrate, leupeptin, phenylmethylsulfonyl fl uoride (PMSF), PNPB, and p -nitrophenol were purchased from Sigma-Aldrich (St. Louis, MO). Digitonin, saponin and tunicamycin were purchased from Wako Pure Chemicals (Osaka, Japan). Proteinase K was purchased from Roche. Adenosine-5 ′ -triphosphate disodium salt trihydrate was purchased from MP Biomedicals. Protein G Sepharose was purchased from Applied Biosystems (GE Healthcare).
in 2% (w/v) BSA in PBS for 1 h at room temperature, enclosed in Perma Fluor Aquaous Mounting Medium (Thermo Shandon) and observed with a Bio-Rad MRC 1024 microscope using a mercury lamp and a 60× objective or with Leica confocal microscopy (Leica) using an argon laser and a 100× objective. The images were processed with Photoshop (Adobe) software.
Deglycosylation
MPMs were suspended in buffer A containing 1% Triton X-100, and 20 µg was treated by PNGase and EndoH (New England Biolabs) according to the manufacturer's protocol.
Tunicamycin treatment
In 12-well plates, HEK293 cells were transfected with pcDNA3.1-based plasmids. After 12 h, media were replaced with DMEM containing 5 µg/ml tunicamycin. Cells were subsequently incubated for 24 h and were scraped into buffer A containing 1% Triton X-100. The prepared lysates were analyzed by Western blotting.
In vitro transcription/translation pcDNA3.1-based plasmids were used for in vitro transcription/ translation using the TNT™ Quick Coupled system (Promega) according to the manufacturer's protocol. The reaction products were analyzed by Western blotting.
Immunoprecipitation
Whole-cell lysates of HEK293 cells (0, 30 or 60 µg) transfected with FLAG-tagged NCEH or HSL were immunoprecipitated by 5 µg of mouse anti-FLAG monoclonal antibody (Sigma-Aidrich), which was bound to Protein G Sepharose. After SDS-PAGE, they were immunoblotted by mouse anti-FLAG monoclonal antibody. Mouse TrueBlot TM ULTRA HRP-Conjugated Anti-Mouse IgG (eBioscience) was used to detect the presence of anti-FLAG antibody.
Phospholylation
HEK293 cells were plated in 12-well plates and the next day transfected with 1 µg of pCMV-Tag4-based plasmids. After 24 h, the cells were preincubated in Krebs-Ringer buffer (25 mM HEPES, 129.4 mM NaCl, 5.2 mM KCl, 1.3 mM MgSO 4 , 50 mM KH 2 PO 4 , 2.5 mM CaCl 2 , 24.8 mM NaHCO 3 , and 2 mM glucose) for 6 h and subsequently incubated fi rst in 1 ml of Krebs-Ringer buffer containing 0.5 mCi [ 32 P] orthophosphate (GE Healthcare) for 1 h and then in the presence or absence of a protein kinase A (PKA) activator, forskolin (20 µM), for 30 min. Cells were suspended in buffer A containing 1% (v/v) Triton X-100 and centrifuged at 15,000 g for 15 min at 4°C. The concentration of protein in the supernatant was determined using a BCA Protein assay kit (Pierce). The supernatant was immunoprecipitated by 5 µg of mouse anti-FLAG monoclonal antibody. After SDS-PAGE, gels were dried, autoradiographed with a Phosphoimager Screen (FUJIFILM), and analyzed using BASTATION (FUJIFILM) software.
Statistical analyses
Results are presented as means ± SE. Student's t -test was employed to compare the means. All calculations were performed with STAT view version 5.0 for Macintosh (SAS Institute). Figure 1A shows the structure of NCEH. It consists of three domains: i ) an N-terminal domain, ii ) a catalytic core antibody was from Sigma-Aldrich. The mouse monoclonal 9E10 anti-myc antibody was from Abcam (Cambridge, UK). The rabbit anti-GFP polyclonal antibody was from MBL (Aichi Japan).
RESULTS
NCEH is a type II ER membrane integrated protein
Western blot analyses
Cells were sonicated in buffer A (50 mmol/l Tris-HCl, pH 7.0, 250 mmol/l sucrose, 1 mmol/l EDTA, and 2 µg/ml leupeptin) and centrifuged at 15,000 g for 15 min at 4°C. Furthermore, the supernatant was used as whole-cell lysate. The supernatant was centrifuged at 100,000 g for 45 min at 4°C. The supernatant was centrifuged under the same conditions again and used as the S100 fraction. The precipitates of the fi rst centrifugation were resuspended and centrifuged at 100,000 g for 45 min at 4°C again. The precipitates were resuspended again and used as a microsomal fraction. Alternatively, cells were suspended in buffer A containing 1% (v/v) Triton X-100 and were centrifuged at 15,000 g for 15 min at 4°C. The supernatant was used in Western blotting. Aliquots (10 µg) of proteins of various cellular fractions were subjected to 10% (w/v) SDS-PAGE and transferred to a nitrocellulose membrane. For detection of the proteins, the membranes were incubated with the appropriate antibody at a dilution of 1:1,000. Specifi cally, bound immunoglobulins were detected in a second reaction with a horseradish peroxidase-labeled IgG conjugate and visualized by enhanced chemiluminescence detection (ECL plus; GE Healthcare) on a Kodak image system.
Enzyme assays
Transfected HEK293 cells were sonicated in buffer A and centrifuged at 15,000 g for 15 min at 4°C. The supernatant was used to assay enzymatic activity. nCEH activity was measured essentially as described by Hajjar, Minick, and Fowler ( 26 ), using a reaction mixture containing 6.14 µM cholesterol [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]oleate (48.8 µCi/µmol; 1 µCi = 37 kBq). PNPB-hydrolyzing activity was determined by measuring the rate of release of p -nitrophenol (absorbance at 405 nm at 37°C) by a modifi ed procedure described previously ( 27 ) .
Proteinase treatment
Permeabilized cells grown in monolayer were used. The method was based on the procedure described previously with minor modifi cations ( 28, 29 ) . MPMs were cultured in 12-well plates to 80% confl uence. Cells were rinsed with PBS and then permeabilized either with 1 µg/ml digitonin in PBS or with 2% (w/v) saponin in PBS, 1.0 ml/well, at room temperature for 10 min. Afterwards, 0.5 ml of buffer B (10 mM Hepes-KOH, pH 7.4, 100 mM NaCl, 10 mM KCl, 1.5 mM MgCl 2 , 5 mM sodium EDTA, and 250 mM sucrose) was added to each well. Protease digestion was started by adding the indicated fi nal concentrations of proteinase K. The digestions proceeded at room temperature for 30 min. The reactions were stopped by addition of PMSF at a fi nal concentration of 5 mM. Cells were suspended in buffer A containing 1% (v/v) Triton X-100 and were centrifuged at 15,000 g for 15 min at 4°C. The supernatant was used for Western blotting.
Immunocytochemistry
Cells were plated in four-chamber plates (Nunc Lab-Tek, Roskilde, Denmark). The culture media were aspirated and cells were fi xed in 3.7% (w/v) PFA in PBS for 30 min at room temperature. Cells were permeabilized by exposure to 0.1% (v/v) Triton X-100, 1 µg/ml digitonin, or 2% (w/v) saponin in PBS for 10 min at room temperature, blocked with 2% (w/v) BSA in PBS for at least 30 min at room temperature and then incubated with primary antibody diluted 1:250 overnight at 4°C. BODIPY 493/503 was used to visualize neutral lipids. To confi rm that NCEH is recruited to the ER, we performed immunostaining for endogenous NCEH in MPMs ( Fig. 2A ) . Staining for NCEH showed a dense reticular network throughout the cells, a pattern characteristic of an ER-based localization. On the other hand, the staining for HSL was diffuse ( Fig. 2A ) . We confi rmed that the staining of NCEH occurred in the ER by using the ER marker protein PDI ( Fig. 2B ) . Cholesterol loading by incubation with acLDL changed neither the pattern of staining ( Fig.  2B ) nor the amount of NCEH protein in either the S100 or microsomal fraction ( Fig. 2C ) .
A similar distribution in the ER localization pattern was observed when GFP-tagged NCEH was overexpressed in RAW264.7 cells ( Fig. 3 ) . The fi ne reticular pattern of staining for GFP completely colocalized with the distribution of the ER marker PDI ( Fig. 3A ) . Cholesterol loading by incubation with acLDL did not change the pattern of staining. To examine whether NCEH is present on lipid droplets (LDs), considered as a principal site for the hydrolysis of neutral lipids, we used BODIPY493/503 to visualize LDs ( Fig. 3B ) . Amounts of myc-tagged NCEH localized around domain, and iii ) a lipid-binding domain, and lacks the regulatory domain present in HSL. The N-terminal region of NCEH contains a hydrophobic region. Figure 1B shows a hydropathy plot of the amino acid sequence of mouse NCEH. Based on this plot, NCEH is a type II membrane protein with a single transmembrane segment containing 23 amino acids. The predicted topology of NCEH is shown in Fig. 1C . In keeping with this prediction, duplets of NCEH proteins were predominantly distributed in the microsomal fraction when MPMs were homogenized by sonication ( Fig. 1D ). This pattern of subcellular distribution is similar to that of ACAT1, an integral ER protein that spans the membrane seven times ( 30, 31 ) but is distinct from that of either PDI, a soluble ER protein, or HSL, a predominantly cytosolic protein ( 32 ) . PDI was distributed in both the S100 and microsomal fractions because PDI, a luminal soluble enzyme, leaked into the S100 fraction during sonication. HSL in macrophages was recognized as double bands as described previously ( 13 ) . The upper band was distributed in the S100 fraction, while the lower band was predominantly distributed in the microsomal fraction. The membrane topology of NCEH predicted by the TMHMM program. D: MPMs fractionated as described in Materials and Methods. S100 and microsomal fractions were prepared by centrifugation of the sonicated MPMs at 100,000 g for 45 min at 4°C twice. Aliquots (10 µg) of whole-cell lysate, the S100, and microsomal fractions were analyzed by Western blotting with anti-NCEH, HSL, ACAT1, and PDI antibodies. Data are representative of three independent experiments. by guest, on August 28, 2017 www.jlr.org
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Treatment with digitonin exposed only cytosolic epitopes, whereas treatment with saponin exposed both cytosolic and ER lumenal epitopes ( Fig. 4A ). Treatment with digitonin visualized only HSL, while treatment with saponin visualized all three proteins, indicating that both NCEH and PDI are located in the ER lumen and that HSL is present in the cytosol.
These results of immunostaining were supported by an experiment in which sensitivity to digestion by proteinase K was compared between different methods of permeabilization. When MPMs were treated with digitonin, NCEH was resistant to proteinase K. However, when treated with saponin, NCEH was sensitive to the proteinase ( Fig. 4B ) .
To determine whether NCEH is a glycoprotein, we treated the membrane fraction with endoglycosidases ( Fig.  4C ) . Treatment with either PNGase F or Endo H converted the double bands (50 and 45 kDa) of NCEH to a single band (40 kDa). Thus, the migration of NCEH as two distinct bands may result from heterogenous glycosylation. Because Endo H mainly catalyzes the deglycosylation of simple glycosylation formed in ER, NCEH's sensitivity to the ring of BODIPY493/503-positive LDs were negligible, and the vast majority of NCEH remained on the ER even after the cholesterol loading.
The catalytic domain is located in the ER lumen
To confi rm that most of NCEH including its catalytic domain and lipid-binding domain is in the ER lumen as predicted by the TMHMM program, we permeabilized MPMs with two different detergents, digitonin and saponin, and performed immunostaining using an antibody against the catalytic domain (99-250 amino acids) of NCEH and antibodies against PDI or HSL as controls. 3 . Positional relation between NCEH protein and lipid droplets in macrophages. A: NCEH-GFP was expressed in RAW264.7 macrophages with or without incubation with 100 µg/ml acLDL for 24 h. Cells were immunostained with mouse anti-PDI monoclonal antibody, followed by Alexa Fluor 555-conjugated secondary antibody. B: NCEH-myc was expressed in RAW264.7 macrophages with or without incubation with 100 µg/ml acLDL for 24 h. Cells were immunostained with mouse monoclonal 9E10 anti-myc antibody, followed by Alexa Fluor 555-conjugated secondary antibody. LDs were stained by BODIPY493/503 (green). Images were acquired with a confocal microscope (Leica) using an argon laser and a 100× objective. These data are representative of three independent experiments. To clarify whether those sites were glycosylated, each asparagine was mutated to glutamine by site-directed mutagenesis. The mutation of asparagine to glutamine is conservative, maintaining characteristics such as polarity or charge on this amino acid residue while preventing glycosylation. These mutations were named N270Q, N367Q, and N389Q. Mutant NCEH proteins containing one, two, or all of the mutations were transiently expressed in HEK293 cells ( Fig. 5B, C ) .
A 50 kDa band, a high molecular weight form of wildtype NCEH, was not observed when mutants contained one of the following three substitutions: N270Q, N367Q, and N389Q ( Fig. 5B ) , indicating that all three asparagine residues are glycosylated. Among the three mutants with a single substitution, only that having N389Q showed a single band ( Fig. 5B ) . On the other hand, among the three with two mutations, only the mutant having N270Q and Endo H indicates that it is located in the ER lumen and does not reach the Golgi where N-linked carbohydrate chains become resistant to Endo H upon modifi cation by mannosidase II in the Golgi. A similar shift in size was observed when HEK 293 cells transfected with the NCEH expression plasmid were incubated with 5 µg/ml tunicamycin, which inhibits N-linked glycosylation ( Fig. 4D ) . NCEH does not receive other types of posttranslational modifi cations because the protein produced by the in vitro transcription/translation of NCEH without microsomes was almost identical in size to NCEH treated with PNGase F ( Fig. 4E ) . ( Fig. 5A ) . To confi rm that the His-Gly dipeptide motif or the GX-SXG active serine motif of serine esterase is critical for enzymatic activity, we made mutants in which the catalytic Gly 114 in HGGG or Ser 191 in GXSXG was replaced by alanine: G114A and S191A, respectively. The PNPB hydrolase activity of each of these mutants was reduced to background levels (see supplementary Fig. II) .
Role of N-linked glycosylation sites in the enzymatic
Role of the N-terminal region in the ER targeting
To determine the role of the N-terminal region of NCEH, we constructed a mutant NCEH that lacks the N-terminal region (1-33 amino acids) ( ⌬ N-NCEH) and expressed it in HEK293 cells ( Fig. 6 ) . Amounts of the expressed ⌬ N-NCEH were signifi cantly reduced compared N367Q showed duplets ( Fig. 5C ). These results indicate that incomplete glycosylation at Asn 389 causes the double band to form. The mutant NCEH containing all three substitutions had the same molecular weight as the wild-type NCEH digested with PNGase F ( Fig. 5C ), confi rming that these three asparagines are only sites for N-linked glycosylation.
To determine which N-linked glycosylation is important for the enzymatic activity, we measured the PNPB hydrolase activity of mutant NCEH proteins ( Fig. 5D ) . The N389Q mutant expressed almost as much PNPB hydrolase activity as the wild-type NCEH. On the other hand, nCEH activitiy levels of the N270Q and N367Q mutants were signifi cantly reduced compared with wild-type NCEH. In particular, the PNPB hydrolase activity of the N270Q mutant was almost reduced to background levels. Hence, N-linked glycosylation in Asn 270 might play an important . IV) . The cell lysates in which HSL or NCEH tagged FLAG was overexpressed were immunoprecipitated by an antibody against the FLAG epitope tag and subjected to either Western blotting for HSL or NCEH (see supplementary Fig. IVA) or autoradiography (see supplementary Fig. IVB) . Phospholylation of the 84 kDa HSL protein, which was further stimulated by treatment with forskolin, a PKA activator, was observed. In contrast, NCEH was not phospholylated even after the treatment with forskolin.
Next, we overexpressed HSL or NCEH in HEK 293 cells by adenovirus-mediated gene transfer and examined the effects of various concentrations of cAMP on the nCEH activity of the expressed enzymes (see supplementary 
DISCUSSION
In this study, we showed that NCEH is tethered to the ER membrane with its catalytic domain residing in the ER lumen. The N-terminal amino acids are required for recruitment to the ER. NCEH contains three potential N-linked glycosylation sites that are all indeed glycosylated. In particular, the N-linked glycosylation at Asn 270 , which is located closest to the catalytic serine, is crucial for the enzymatic activity.
NCEH belongs to a family of ER proteins that are resident and catalytically active in the ER lumen. The best characterized proteins targeting this compartment are soluble and bear the C-terminal sequence KDEL ( 36, 37 ) . NCEH belongs to another group of proteins that are membrane bound and lack the ER retrieval sequence. Most ER proteins involved in lipid biosynthesis have a polytopic topology: examples are HMG-CoA reductase, ACAT, diacylglycerol acyltransferase, and insig1. In contrast, NCEH has a bitopic topology: it is a type II membrane protein with its C-terminal projecting to the ER lumen. The N-terminal hydrophobic segment is the transmembrane domain that tethers NCEH to the ER membrane. In addition to anchoring the protein, the N-terminal segment (1-33 amino acids) containing the hydrophobic segment (4-26 amino acids) functions as a motif targeting the ER with those of wild-type NCEH ( Fig. 6A ) . Furthermore, the expressed ⌬ N-NCEH was a single band whose molecular weight was as small as that of wild-type NCEH treated with PNGase F or the mutant NCEH lacking all three potential N-linked glycosylation sites, suggesting that the ⌬ N-NCEH mutant did not undergo N-linked glycosylation. Consistent with this prediction, PNGase F treatment did not change the molecular weight of the ⌬ N-NCEH mutant ( Fig. 6A ) . ⌬ N-NCEH was not detected in the media where the cells expressing ⌬ N-NCEH were incubated (data not shown). These results indicate that the N-terminal region of NCEH regulates the stability of the protein and that ⌬ N-NCEH is not glycosylated.
Next, we took advantage of GFP-fused forms of several mutant proteins to determine the subcellular distribution of NCEH within Hela cells ( Fig. 6B-H ) . NCEH-GFP colocalized with an ER marker protein, PDI ( Fig. 6D ) . This is different from the diffuse cytoplasmic expression of GFP ( Fig. 6C ) . NCEH-myc and NCEH-GFP colocalized when cotransfected ( Fig. 6D ) , indicating that fusion of the GFP protein to the C-terminal end of NCEH did not infl uence the subcellular disnribution. On the other hand, ⌬ N-NCEH-GFP was distributed throughout the cell uniformly and did not colocalize with NCEH-myc ( Fig. 6F ) . NCEH 1-33 -GFP, comprising the N-terminal region of NCEH (1-33 amino acids) fused directly with GFP, mostly colocalized with NCEH-myc ( Fig. 6G ) . In addition to the ER, however, NCEH 1-33 -GFP was also found in the perinuclear region, where it was not localized with NCEH-myc. NCEH 1-89 -GFP, comprising the N-terminal amino acids (1-89 amino acids) of NCEH fused directly with GFP, entirely colocalized with NCEH-myc ( Fig. 6H ) . These results indicate that the N-terminal region of NCEH serves as a type II signal anchor sequence which directs NCEH to the ER with its C-terminal side within the lumen (Ncyt/Cexo) ( 33 ) .
Corroborating the results of immunostaining, Western blotting showed that the anti-GFP antibody detected both NCEH and NCEH 1-33 -GFP exclusively in the microsomal fraction, whereas it detected GFP itself almost exclusively in the S100 fraction (see supplementary Fig. III) , supporting our premise that the N-terminal region of NCEH is a transmembrane domain.
NCEH is not a target of PKA
As deduced from the structural comparison with HSL, NCEH lacks a regulatory domain that contains many potential phospholylation sites for the regulation of enzymatic activities ( Fig. 1A ) . To confi rm that NCEH is not phospholylated, we overexpressed FLAG-tagged HSL or NCEH in HEK293 cells and cultured them in low phosphate media. After 6 h, the transfected cells were absence of PNGase F. Data are representative of three independent experiments. GFP, NCEH-GFP, ⌬ N-NCEH-GFP, NCEH 1-33 -GFP, and NCEH 1-89 -GFP (B) were expressed as GFP fusion proteins in Hela cells. The cells were immunostained with mouse anti-PDI monoclonal antibody followed by Alexa Fluor 555-conjugated secondary antibody. In other sets of experiments, cells were cotransfected with pcDNA3.1-NCEH-myc and immunostained by mouse monoclonal 9E10 anti-myc antibody, followed by Alexa Fluor 555-conjugated secondary antibody. The intracellular distribution of these GFP fusion proteins was compared with that of PDI (C and D) of NCEH-myc (E-H). Images were acquired by confocal microscopy (Leica) using an argon laser and a 100× objective. Data are representative of three independent experiments. by guest, on August 28, 2017 www.jlr.org Downloaded from current model, as lipid pools between the two leafl ets of the ER enlarge, LDs are formed from the budding of cytoplasmic leafl ets surrounding a lipid pool. Probably, CE synthesized by ACAT1, an ER polytopic protein with its catalytic site facing the cytoplasm ( 30, 31 ) , accumulates in LDs in macrophages through the same pathway ( 45 ) . Most LDs remain attached to the ER. Communication between LDs and ER may be more active than has been considered. For example, Rab 18 is present on LDs and its overexpression increases the association of LDs with the ER ( 46, 47 ) . Therefore, it may not necessary to postulate a direct role for NCEH in the hydrolysis of CE in the LDs. CE in the LDs is continuously undergoing a futile cycle of hydrolysis, transport of the sterol to the ER for reesterifi cation, and transport back to the LDs. NCEH may alter CE content in the LDs by disrupting this cycle. The apparently paradoxical hydrolysis of neutral lipids in LDs by ER luminal enzymes is also observed in adipocytes and possibly hepatocytes. TGH (TGH-1, hCE-1, and CEH) and TGH-2, which are mainly localized to the ER lumen, hydrolyzes triglyceride in LDs of hepatocytes and/or adipocytes ( 48 ) .
It was reported that nCEH activity is increased by cAMP in WEHI, P388D1, or J774 macrophages (49) (50) (51) . In this study, the nCEH activity of lysates prepared from MPMs was increased 20% by cAMP, but the difference was not significant. Previously, we reported that NCEH plays a major role in the nCEH activity of MPMs ( 13 ) . On the other hand, it is thought that HSL plays a greater role than NCEH in the nCEH activity of macrophage immortal cell lines, such as RAW264.7 and J774 (13) . It depends on the ratio of expression of NCEH and HSL whether the nCEH activity of macrophage cell lysates is signifi cantly increased by cAMP.
In summary, NCEH is a single-membrane-spanning ER protein that anchors to the ER membrane with an N-terminal hydrophobic segment. Its catalytic and lipidbinding domains are located in the ER lumen. The N-terminal region serves as a signal sequence that recruits NCEH to the ER lumen. N-linked glycosylation at Asn 270 is crucial for its enzymatic activity. Elucidation of the mechanisms by which NCEH removes cholesterol from macrophage foam cells would pave the way for the development of novel therapies for the prevention of atherosclerosis.
Note added in proof
NCEH1 has been registered as an offi cial name of NCEH, KIAA1363, or AADACL1 in HUGO. After acceptance of this paper, we reported the generation and phenotypic analysis of mice lacking Nceh1 ( Cell Metab . 2009. 10:219-228).
because NCEH deleted of this segment does not distribute in the ER, which is consistent with the loss of N-linked glycosylation of ⌬ N-NCEH. A longer stretch of the N terminus (1-89 amino acids) is required for the exact same distribution as wild-type NCEH. These features are consistent with the view that most ER proteins are recruited for insertion into membrane by a hydrophobic signal peptide at the N terminus ( 38 ) . The specifi c topology of proteins is determined by factors like charge distribution, the length of the membrane segment and the charge of the segments following the membrane segment ( 39 ) . Ozols and his colleagues proposed the existence of lumental targeting signal based on a comparison of the N-terminal transmembrane domains of two functionally distinct proteins: 11 ␤ -hydroxysteroid dehydrogenase, isozyme 1 (11 ␤ -HSD) and 50 kDa esterase (E3) ( 40 ) . According to their model, an amino acid sequence consisting of short basic or neutral residues at the N terminus, followed by a specifi c array of hydrophobic residues terminating with acidic residues, is suffi cient for lumental targeting of single-pass proteins. The amino acid sequence of the N terminus of NCEH is almost compatible with this model. Of note, region II of NCEH contains a cluster of tyrosyl residues (AYYXY) that are shared by 11 ␤ -SHD and E3.
NCEH is fully deglycosylated by Endo H ( Fig. 4C ), indicating that NCEH is localized to the ER and not transported to the Golgi body. Site-directed mutagenesis showed that all three putative N-glycosylation sites of NCEH (Asn 270 , Asn 367 , and Asn
389
) are glycosylated ( Fig.  5B ). In particular, N-linked glycosylation at Asn 270 plays an important role in catalysis ( Fig. 5D ). The presence of N-oligosaccharides is required for the correct folding of many glycoproteins ( 41 ) . N-linked glycosylation at Asn 270 may play a more important role in the correct folding of NCEH. Asn 389 was important for NCEH to form double bands (Fig. 5B, C) is not important for the enzymatic activity of NCEH ( Fig.  5D ), the forms of NCEH differing in glycosylation at Asn 389 may have similar enzymatic activity. A functional difference between these two is currently unknown. Generally, the CE accumulated in macrophage foam cells is in LDs and its hydrolysis requires the association of the CE hydrolases with LDs. Indeed, HSL and CEH are largely cytosolic proteins. Egan et al. ( 32 ) reported that HSL translocates from the cytosol to LDs upon stimulation with catecholamines in adipocytes. Zhao et al. ( 42 ) reported that CEH translocates to LDs upon cholesterol loading in macrophages. Yet, hCE-1 and TGH, synonyms of CEH, have been reported to distribute to the ER via its C-terminal ER targeting signal, HIEL, in hepatocytes ( 43 ) . It is unknown why subcellular localization of the same protein is different between different types of cells. In contrast to these two cytosolic enzymes, it is diffi cult to imagine how NCEH, an ER protein with its catalytic domain in the ER lumen, hydrolyses CE, which accumulates in LDs in foam cells primarily increasing the effl ux of cholesterol from THP-1 cells ( 13 ) . Recently, our understanding of the biogenesis of LDs in adipocytes has rapidly advanced ( 44 ) . According to the by guest, on August 28, 2017 www.jlr.org Downloaded from
